48 ( 53 % ) patients in the rhPTH ( 1-84 ) group achieved the primary endpoint compared with one ( 2 % ) patient in the placebo group ( percentage difference 51.1 % , 95 % CI 39.9-62 .3 ; p < 0.0001 ) .